Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Alcon Inc (NY: ALC ) 78.77 -0.07 (-0.09%) Official Closing Price Updated: 7:00 PM EDT, Apr 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,115,931 Open 78.32 Bid (Size) 78.34 (1) Ask (Size) 90.63 (1) Prev. Close 78.84 Today's Range 78.30 - 79.00 52wk Range 69.44 - 88.23 Shares Outstanding 489,219,355 Dividend Yield 0.30% Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Star Surgical Shines as U.S. Outlook Improves for 2024 April 16, 2024 STAAR Surgical is increasing its outlook and guidance as demand for its signature IOL procedure increases with an aging population Via MarketBeat Alcon Publishes Agenda for 2024 Annual General Meeting April 07, 2024 From Alcon Inc. Investors Via Business Wire Performance YTD +2.25% +2.25% 1 Month -5.43% -5.43% 3 Month +3.54% +3.54% 6 Month +11.86% +11.86% 1 Year +8.68% +8.68% More News Read More Alcon Inc. (NYSE: ALC) Records 52-Week High Tuesday Morning March 12, 2024 Via Investor Brand Network Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone March 06, 2024 From Alcon Inc. Corporate Via Business Wire What 6 Analyst Ratings Have To Say About Alcon December 04, 2023 Via Benzinga The Latest Analyst Ratings for Alcon November 16, 2023 Via Benzinga Why Medical Device Company Alcon Shares Are Sliding Today November 15, 2023 Via Benzinga Alcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023 February 27, 2024 From Alcon Inc. Investors Via Business Wire Earnings Preview: What To Expect To When Eye Health Company Bausch + Lomb Reports Q4 Performance Later This Month February 09, 2024 Via Benzinga Buy This Ophthalmology Stock But Sell This One, Says Bernstein Analyst: 'Innovation Is Key' January 23, 2024 Via Benzinga Good News For Dry Eye Disease Patients: Eye Care Focused Alcon's Treatment Shows Encouraging Benefit In Late-Stage Trials January 10, 2024 Via Benzinga Where Alcon Stands With Analysts September 08, 2023 Via Benzinga Alcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry Eye January 09, 2024 From Alcon Inc. Investors Via Business Wire Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements January 05, 2024 From Lifecore Biomedical, Inc. Via GlobeNewswire Alcon to Present at 2024 Annual J.P. Morgan Healthcare Conference December 27, 2023 From Alcon Inc. Investors Via Business Wire Intel To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Thursday November 16, 2023 Via Benzinga Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session November 15, 2023 Via Benzinga US Stocks On Track To Build On Gains As Traders Await A Batch Of Data; Can Market Resist Profit Taking? November 15, 2023 Via Benzinga Topics Economy Exposures Interest Rates Varex Imaging Reports Weak Sales, Joins Alcon, XPeng And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session November 15, 2023 Via Benzinga Topics Stocks Exposures US Equities Alcon Reports Third Quarter 2023 Results November 14, 2023 From Alcon Inc. Investors Via Business Wire Alcon Gears Up For Q3 Print; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts November 14, 2023 Via Benzinga Alcon Showcases Cloud-based Planning and World-class Digital Technologies During AAO 2023 October 30, 2023 From Alcon Inc. Investors Via Business Wire Alcon Launches TOTAL30 Multifocal Contact Lenses for Patients with Presbyopia October 10, 2023 From Alcon Inc. Investors Via Business Wire Cataract Surgery with Alcon’s AcrySof IQ Vivity IOLs Demonstrates Sustained High Patient Satisfaction and Reduced Spectacle Dependence September 09, 2023 From Alcon Inc. Corporate Via Business Wire Global Dry Eye Syndrome Treatment Market Expected to Reach $11.26 Billion By 2030 September 08, 2023 Via FinancialNewsMedia Exposures COVID-19 Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.